Comparison of two kinds of nanomedicine for targeted gene therapy: Premodified or postmodified gene delivery systems

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 2019-2031

  Jiang, Zhaoshun ^a   Sun, Cong ^a   Yin, Zhaohui ^a   Zhou, Fang ^a   Ge, Linfu ^a   Liu, Ximin ^a   Kong, Fansheng ^a  

^a JINAN MILITARY GENERAL HOSPITAL   (China)

Author keywords

Gene therapy; L phosphatidylethanolamine; Ligands; Mannan; Nanomedicine; Polyethylene glycol; Postmodification; Premodification

Indexed keywords

MANNAN POLYETHYLENE GLYCOL LEVO ALPHA PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLETHANOLAMINE; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG; DIOLEOYL N (MONOMETHOXYPOLYETHYLENE GLYCOL SUCCINYL)PHOSPHATIDYLETHANOLAMINE; DIOLEOYL-N-(MONOMETHOXYPOLYETHYLENE GLYCOL SUCCINYL)PHOSPHATIDYLETHANOLAMINE; DNA; DRUG CARRIER; LIPID; MACROGOL DERIVATIVE; MANNAN; NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE TARGETING; GENE VECTOR; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; KUPFFER CELL; MALE; NANOMEDICINE; NONHUMAN; PROCESS OPTIMIZATION; QUANTITATIVE ANALYSIS; RAT; STRUCTURE ANALYSIS; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; DRUG DELIVERY SYSTEM; GENE THERAPY; GENETIC TRANSFECTION; GENETICS; METABOLISM; METHODOLOGY; WISTAR RAT;

RATTUS;

ANIMALS; DNA; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; KUPFFER CELLS; LIPIDS; MALE; MANNANS; NANOMEDICINE; NANOPARTICLES; PHOSPHATIDYLETHANOLAMINES; POLYETHYLENE GLYCOLS; RATS; RATS, WISTAR; TRANSFECTION;

EID: 84866752071     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S30928     Document Type: Article

References (42)

1. Pathak A, Vyas SP, Gupta KC. Nano-vectors for efficient liver specific gene transfer. Int J Nanomedicine. 2008;3(1):31-49.
2. Torchilin VP. Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J. 2007;9(2):E128-E147.
3. Kim SK, Park KM, Singha K, et al. Galactosylated cucurbituril-inclusion polyplex for hepatocyte-targeted gene delivery. Chem Commun (Camb). 2010;46(5):692-694.
4. Boulaiz H, Marchal JA, Prados J, Melguizo C, Aránega A. Non-viral and viral vectors for gene therapy. Cell Mol Biol (Noisy-le-grand). 2005;51(1):3-22.
5. Zhao XB, Lee RJ. Tumor-selective targeted delivery of genes and antisense oligodeoxyribonucleotides via the folate receptor. Adv Drug Deliv Rev. 2004;56(8):1193-1204.
6. Torchilin VP. Multifunctional nanocarriers. Adv Drug Deliv Rev. 2006;58(14):1532-1555.
7. Yu W, Zhang N. Surface modification of nanocarriers for cancer therapy. Curr Nanosci. 2009;5(2):123-134.
8. Li SD, Huang L. Surface-modified LPD nanoparticles for tumor targeting. Ann N Y Acad Sci. 2006;1082:1-8.
9. Juillerat-Jeanneret L, Schmitt F. Chemical modification of therapeutic drugs or drug vector systems to achieve targeted therapy: looking for the grail. Med Res Rev. 2007;27(4):574-590.
10. Chavanpatil MD, Khdair A, Panyam J. Nanoparticles for cellular drug delivery: mechanisms and factors influencing delivery. J Nanosci Nanotechnol. 2006;6(9-10):2651-2663.
11. Peeters L, Sanders NN, Jones A, Demeester J, De Smedt SC. Postpegylated lipoplexes are promising vehicles for gene delivery in RPE cells. J Control Release. 2007;121(3):208-217.
12. Kolhatkar RB, Kitchens KM, Swaan PW, Ghandehari H. Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability. Bioconjug Chem. 2007;18(6):2054-2060.
13. Kojima C, Kono K, Maruyama K, Takagishi T. Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs. Bioconjug Chem. 2000;11(6):910-917.
14. Patri AK, Kukowska-Latallo JF, Baker JR Jr. Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex. Adv Drug Deliv Rev. 2005;57(15):2203-2214.
15. Forrest ML, Zhao A, Won CY, Malick AW, Kwon GS. Lipophilic prodrugs of Hsp90 inhibitor geldanamycin for nanoencapsulation in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles. J Control Release. 2006;116(2):139-149.
16. Weiss B, Schneider M, Muys L, et al. Coupling of biotin-(poly(ethylene glycol)amine to poly(D, L-lactide-co-glycolide) nanoparticles for versatile surface modification. Bioconjug Chem. 2007;18(4):1087-1094.
17. Li SD, Chen YC, Hackett MJ, Huang L. Tumor-targeted delivery of siRNA by self-assembled nanoparticles. Mol Ther. 2008;16(1):163-169.
18. Yamada M, Nishikawa M, Kawakami S, et al. Tissue and intrahepatic distribution and subcellular localization of a mannosylated lipoplex after intravenous administration in mice. J Control Release. 2004;98(1):157-167.
19. Kitani H, Takenouchi T, Sato M, Yoshioka M, Yamanaka N. A novel isolation method for macrophage-like cells from mixed primary cultures of adult rat liver cells. J Immunol Methods. 2010;360(1-2):47-55.
20. Yu W, Liu C, Liu Y, Zhang N, Xu W. Mannan-modified solid lipid nanoparticles for targeted gene delivery to alveolar macrophages. Pharm Res. 2010;27(8):1584-1596.
21. Lobovkina T, Jacobson GB, Gonzalez-Gonzalez E, et al. In vivo sustained release of siRNA from solid lipid nanoparticles. ACS Nano. 2011;5(12):9977-9983.
22. Zhang S, Yun J, Shen S, et al. Formation of solid lipid nanoparticles in a microchannel system with a cross-shaped junction. Chem Eng Sci. 2008;63(23):5600-5605.
23. Ahn SJ, Costa J, Emanuel JR. PicoGreen quantitation of DNA: effective evaluation of samples pre-or post-PCR. Nucleic Acids Res. 1996;24(13):2623-2635.
24. Ren X, Xu QH. Label-free DNA sequence detection with enhanced sensitivity and selectivity using cationic conjugated polymers and PicoGreen. Langmuir. 2009;25(1):43-47.
25. Ikeda Y, Iwakiri S, Yoshimori T. Development and characterization of a novel host cell DNA assay using ultra-sensitive fluorescent nucleic acid stain "PicoGreen". J Pharm Biomed Anal. 2009;49(4): 997-1002.
26. Lee JY, Cheong IW, Kim JH. Agglutination study of poly(allyl-alpha-Dglucopyranose/ styrene) latex particles in the presence of concanavalin A. Colloids Surf B Biointerfaces. 2005;41(2-3):203-208.
27. Cui Z, Han SJ, Huang L. Coating of mannan on LPD particles containing HPV E7 peptide significantly enhances immunity against HPV-positive tumor. Pharm Res. 2004;21(6):1018-1025.
28. Cui Z, Mumper RJ. Topical immunization using nanoengineered genetic vaccines. J Control Release. 2002;81(1-2):173-184.
29. Kong F, Zhou F, Ge L, Liu X, Wang Y. Mannosylated liposomes for targeted gene delivery. Int J Nanomedicine. 2012;7:1079-1089.
30. Gao Y, Gu W, Chen L, Xu Z, Li Y. A multifunctional nano device as non-viral vector for gene delivery: in vitro characteristics and transfection. J Control Release. 2007;118(3):381-388.
31. Yu W, Liu C, Ye J, Zou W, Zhang N, Xu W. Novel cationic SLN containing a synthesized single-tailed lipid as a modifier for gene delivery. Nanotechnology. 2009;20(1):215102.
32. van Vlerken LE, Vyas TK, Amiji MM. Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery. Pharm Res. 2007;24(8):1405-1414.
33. Lukyanov AN, Gao Z, Mazzola L, Torchilin VP. Polyethylene glycoldiacyl lipid micelles demonstrate increased accumulation in subcutaneous tumors in mice. Pharm Res. 2002;19(10):1424-1429.
34. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 2005;4(2):145-160.
35. Torchilin VP. Micellar nanocarriers: pharmaceutical perspectives. Pharm Res. 2007;24(1):1-16.
36. Yang L, Wang L, Su XQ, et al. Suppression of ovarian cancer growth via systemic administration with liposome-encapsulated adenovirusencoding endostatin. Cancer Gene Ther. 2010;17(1):49-57.
37. Yu W, Zhang N, Li C. Saccharide modified pharmaceutical nanocarriers for targeted drug and gene delivery. Curr Pharm Des. 2009;15(32): 3826-3836.
38. Sawant RM, Hurley JP, Salmaso S, et al. "SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers. Bioconjug Chem. 2006;17(4):943-949.
39. Summer JB, Howell SF. The identification of the hemagglutinin of the jack bean with concanavalin A. J Bacteriol. 1936;32(2):227-237.
40. Barre A, Bourne Y, Van Damme EJ, Peumans WJ, Rouge P. Mannose-binding plant lectins: different structural scaffolds for a common sugar-recognition process. Biochimie. 2001;83(7):645-651.
41. Kizhakkedathu JN, Creagh AL, Shenoi RA, et al. High molecular weight polyglycerol-based multivalent mannose conjugates. Biomacromolecules. 2010;11(10):2567-2575.
42. Wolfenden ML, Cloninger MJ. Mannose/glucose-functionalized dendrimers to investigate the predictable tunability of multivalent interactions. J Am Chem Soc. 2005;127(35):12168-12169.